|
CN111249229A
|
|
Stable favipiravir injection and preparation method thereof
|
|
CN107445994A
|
|
Tenofovir Chinese mugwort draws phenol amine hemifumarate novel crystal forms
|
|
CN109125271A
|
|
A method of containing Favipiravir midbody particle using fluidized bed preparation
|
|
CN108498459A
|
|
A kind of pharmaceutical composition and preparation method thereof including hydrobromic acid Vortioxetine
|
|
CN107913257A
|
|
A kind of pharmaceutical composition comprising rosuvastain calcium and preparation method thereof
|
|
CN107913255A
|
|
A kind of tablet containing Omeprazole and preparation method thereof
|
|
CN107913247A
|
|
A kind of Levetiracetam injection preparation and preparation method thereof
|
|
CN107913245A
|
|
A kind of preparation method of Levetiracetam sodium chloride injection
|
|
CN107915735A
|
|
The improvement in synthesis of istradefylline
|
|
CN107915715A
|
|
A kind of synthetic method of rosuvastatin calcium side chain key intermediate
|
|
CN107915675A
|
|
A kind of preparation method of high-purity distigmine bromide
|
|
CN107915688A
|
|
A kind of method for improving synthesis process of Tofisopam
|
|
CN107913258A
|
|
A kind of levetiracetam sustained-release tablets and preparation method thereof
|
|
CN107915667A
|
|
A kind of improved method of Levetiracetam synthesis technique
|
|
CN107915694A
|
|
1 [2 (2,4 3,5-dimethylphenyl sulfydryl) phenyl] piperazine hydrochloride and preparation method thereof
|
|
CN105640877A
|
|
Liquid preparation containing Vonoprazan
|
|
CN106924205A
|
|
A kind of sustained release preparation containing Baricitinib
|
|
CN105412038A
|
|
Compound preparation containing vonoprazan and non-steroidal anti-inflammatory drugs
|
|
CN105985250A
|
|
Fesoterodine fumarate crystal form and preparation method thereof
|
|
CN105748410A
|
|
Preparation technique for improving dissolution rate and stability of insoluble drug
|
